Moderna, Inc. (NASDAQ:MRNA) Q4 2023 Earnings Call Transcript February 22, 2024 Moderna, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Moderna Fourth Quarter 2023 Conference Call. At this […]
Related Keywords
Germany , United Kingdom , Australia , Massachusetts , United States , Canada , Stephen Hoge , Michael Yee , , New England Journal , Individualized Neoantigen Therapy , For Moderna , Guillain Barre Syndrome , English Speaking Countries ,
comparemela.com © 2020. All Rights Reserved.